The HSP90 inhibitor 17-AAG potentiates the antileishmanial activity of the ether lipid edelfosine. [electronic resource]
Producer: 20141003Description: 32-6 p. digitalISSN:- 1873-6254
- Apoptosis -- drug effects
- Benzoquinones -- pharmacology
- Culture Media
- Dose-Response Relationship, Drug
- Drug Synergism
- Drug Therapy, Combination
- G1 Phase Cell Cycle Checkpoints -- drug effects
- Gene Expression
- HSP90 Heat-Shock Proteins -- antagonists & inhibitors
- Lactams, Macrocyclic -- pharmacology
- Leishmania -- drug effects
- Leishmania infantum -- drug effects
- Phospholipid Ethers -- pharmacology
- Protozoan Proteins -- antagonists & inhibitors
- Resting Phase, Cell Cycle -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.